PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Richard G Wunderink Selected Research
Pneumonia (Pneumonitis)
12/2007
4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.
07/2006
Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.
04/2006
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.
12/2004
Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.
05/2004
Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia.
11/2003
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
09/2003
High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.
05/2003
Heat shock protein 70-2+1267 AA homozygotes have an increased risk of septic shock in adults with community-acquired pneumonia.
03/2003
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
03/2002
Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia.
Articles by Research Topic
Disease
10
Pneumonia (Pneumonitis)
12/2007 - 03/2002
1
Respiratory Tract Infections (Respiratory Tract Infection)
12/2004
1
Respiratory Insufficiency (Respiratory Failure)
05/2004
1
Ventilator-Associated Pneumonia (Pneumonia, Ventilator Associated)
03/2004
1
Septic Shock (Toxic Shock Syndrome)
05/2003
Drug/Important Bio-Agent (IBA)
4
Vancomycin
FDA Link
Generic
04/2006 - 03/2003
3
linezolid (Zyvox)
FDA Link
03/2004 - 03/2003
1
Plasminogen Activators (Plasminogen Activator)
IBA
12/2007
1
Anti-Bacterial Agents (Antibiotics)
IBA
07/2006
1
Integration Host Factors (Host Factor)
IBA
12/2004
1
IgA receptor (protein B)
IBA
05/2004
1
Ofloxacin (Levofloxacin)
FDA Link
Generic
09/2003
1
HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
IBA
05/2003
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2002